Epstein–Barr Virus Promotes Oral Squamous Cell Carcinoma Stemness through the Warburg Effect
International Journal of Molecular Sciences · 14.09.2023 · 24 (18) · 14072
DOI: 10.3390/ijms241814072 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.09.2023. Verfasst von Chukkris Heawchaiyaphum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Technology, Thammasat University (Rangsit Center), Pathum Thani 12120, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Epstein-Barr Virus Infections, Head and Neck Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) is associated with various human malignancies. An association between EBV infection and oral squamous cell carcinoma (OSCC) has recently been reported. We established EBV-positive OSCC cells and demonstrated that EBV infection promoted OSCC progression. However, the mechanisms by which EBV promotes OSCC progression remain poorly understood. Therefore, we performed metabolic analyses of EBV-positive OSCC cells and established a xenograft model to investigate the viral contribution to OSCC progression. Here, we demonstrated that EBV infection induced mitochondrial stress by reducing the number of mitochondrial DNA (mtDNA) copies. Microarray data from EBV-positive OSCC cells showed altered expression of glycolysis-related genes, particularly the upregulation of key genes involved in the Warburg effect, including LDHA, GLUT1, and PDK1. Furthermore, lactate production and LDH activity were elevated in EBV-positive OSCC cells. EBV infection significantly upregulated the expression levels of cancer stem cell (CSC) markers such as CD44 and CD133 in the xenograft model. In this model, tumor growth was significantly increased in EBV-positive SCC25 cells compared with that in uninfected cells. Furthermore, tumorigenicity increased after serial passages of EBV-positive SCC25 tumors. This study revealed the oncogenic role of EBV in OSCC progression by inducing the Warburg effect and cancer stemness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Faculty of Science and Technology, Thammasat University (Rangsit Center), Pathum Thani 12120, Thailand.
- Department of Microbiology, Faculty of Medicine, Shimane University, Shimane 693-8501, Japan.
- Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
- HPV & EBV and Carcinogenesis Research Group, Khon Kaen University, Khon Kaen 40002, Thailand.
ORCID-Profile: Hironori Yoshiyama, Hisashi Iizasa, Ati Burassakarn, Tipaya Ekalaksananan, Chamsai Pientong
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
Zitieren
APA
Heawchaiyaphum, C., Yoshiyama, H., Iizasa, H., Burassakarn, A., Tumurgan, Z., Ekalaksananan, T., & Pientong, C. (2023). Epstein–Barr Virus Promotes Oral Squamous Cell Carcinoma Stemness through the Warburg Effect. International Journal of Molecular Sciences, 24(18), 14072. https://doi.org/10.3390/ijms241814072
Vancouver
Heawchaiyaphum C, Yoshiyama H, Iizasa H, Burassakarn A, Tumurgan Z, Ekalaksananan T, et al. Epstein–Barr Virus Promotes Oral Squamous Cell Carcinoma Stemness through the Warburg Effect. International Journal of Molecular Sciences. 2023;24(18):14072. doi:10.3390/ijms241814072
BibTeX
@article{Heawchaiyaphum2023,
author = {Heawchaiyaphum, Chukkris and Yoshiyama, Hironori and Iizasa, Hisashi and Burassakarn, Ati and Tumurgan, Zolzaya and Ekalaksananan, Tipaya and Pientong, Chamsai},
title = {Epstein–Barr Virus Promotes Oral Squamous Cell Carcinoma Stemness through the Warburg Effect},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {14072},
doi = {10.3390/ijms241814072}
}
EUVIMED